Star Imaging & Path Lab Ltd.
BBSE:STARIMAGIN77.00
INR
+5.25
(+7.32%)
ISIN
INE0YG001013
Return %
Stock
S&P 500
1Y
-40.63
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Semi-annual Revenue
INR
•
in mil. unless spec.Semi-annual Earnings Per Share
INR
•
in mil. unless spec.Semi-annual Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Pawan Gupta
- Full Time Employees
- 236
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- New Delhi India
- IPO Date
- Aug 18, 2025
- Website
- starimaging.in
- Similar Companies
- Business
- Star Imaging & Path Lab Ltd. provides integrated diagnostic healthcare, medical imaging, and clinical pathology laboratory services in India. The company operates across two core business segments: Diagnostic Imaging (Radiology) and Clinical Laboratory Testing (Pathology). Its diagnostic radiology and medical imaging portfolio includes high-field magnetic resonance imaging (MRI); multi-slice computed tomography (CT) scans; digital radiography and routine X-rays; 3D and 4D ultrasound imaging; color Doppler studies; digital mammography; bone mineral densitometry (BMD/DEXA scans); positron emission tomography-computed tomography (PET-CT); electrocardiography (ECG); 2D echocardiography (ECHO); treadmill stress testing (TMT); pulmonary function testing (PFT); and electroencephalography (EEG). Its clinical pathology and laboratory services comprise clinical biochemistry; hematology and coagulation profiles; clinical pathology and urinalysis; microbiology and serology; histopathology and immunohistochemistry; cytopathology; immunology and endocrinology; infectious disease assays; molecular diagnostics; and specialized genetic screening tests. In addition, the company offers comprehensive preventive health check-up packages; chronic disease management profiles; prenatal and women health screening packages; oncology screening panels; corporate wellness and occupational health programs; pre-employment medical examinations; home sample collection services; mobile diagnostic vans; and digital tele-radiology reporting solutions catering to individual patients, corporate clients, medical practitioners, and healthcare institutions. In recent developments, Star Imaging & Path Lab Ltd. completed its public listing on the BSE SME platform (BSE: STARIMAGIN) to finance geographic network expansion, equipment modernization, and laboratory infrastructure upgrades. Over the past two years, the company has expanded its presence across the National Capital Region (Delhi-NCR) and northern India through the addition of new automated collection centers, hub-and-spoke processing facilities, and public-private partnership (PPP) diagnostic centers with regional government hospitals. The company has also integrated artificial intelligence-assisted imaging tools for accelerated radiological interpretation, broadened its molecular diagnostics and specialized pathology test menu, and established strategic diagnostic partnerships with institutional healthcare networks and corporate employers. Star Imaging & Path Lab Ltd. was founded in 1978 and is headquartered in New Delhi, India.